Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 18/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 0.94 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.94 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.94 |
| ▸ | RECQL | P46063 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296882 | 0.97 | GPR84 (1.00) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL297291 | 0.93 | GPR84 (0.86) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL297523 | 0.92 | GPR84 (0.90) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL21615618 | 0.91 | GPR84 (1.00) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL887278 | 0.90 | GPR84 (1.00) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL21615616 | 0.90 | GPR84 (1.00) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL15079017 | 0.89 | GPR84 (0.84) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL14327762 | 0.89 | GPR84 (0.84) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL296790 | 0.88 | GPR84 (1.00) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL13156444 | 0.88 | MEN1 (1.00) | GPR84MEN1KMT2AKDM4ERECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020007342-A1 | APPLICATION OF BIPHENYL PHOSPHATE COMPOUND AS GPR84 ANTAGONIST | 中国科学院上海药物研究所 | 2020-01-09 | — | — | WO | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | GPR84 2711/4885MEN1 194/4885KMT2A 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.